Perspective Therapeutics (CATX) Other Non-Current Liabilities (2016 - 2025)
Historic Other Non-Current Liabilities for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $342000.0.
- Perspective Therapeutics' Other Non-Current Liabilities rose 93636.36% to $342000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $342000.0, marking a year-over-year increase of 93636.36%. This contributed to the annual value of $55000.0 for FY2024, which is N/A changed from last year.
- Latest data reveals that Perspective Therapeutics reported Other Non-Current Liabilities of $342000.0 as of Q3 2025, which was up 93636.36% from $284000.0 recorded in Q2 2025.
- Perspective Therapeutics' Other Non-Current Liabilities' 5-year high stood at $668000.0 during Q3 2023, with a 5-year trough of $19000.0 in Q2 2024.
- Its 5-year average for Other Non-Current Liabilities is $464529.4, with a median of $616000.0 in 2021.
- In the last 5 years, Perspective Therapeutics' Other Non-Current Liabilities plummeted by 9711.68% in 2024 and then skyrocketed by 139473.68% in 2025.
- Perspective Therapeutics' Other Non-Current Liabilities (Quarter) stood at $624000.0 in 2021, then rose by 5.29% to $657000.0 in 2022, then increased by 1.67% to $668000.0 in 2023, then plummeted by 91.77% to $55000.0 in 2024, then skyrocketed by 521.82% to $342000.0 in 2025.
- Its Other Non-Current Liabilities stands at $342000.0 for Q3 2025, versus $284000.0 for Q2 2025 and $145000.0 for Q1 2025.